Kidney Research and Clinical Practice

Search

Page Path

A multicenter, randomized, open-label, comparative, phase IV study to evaluate the efficacy and safety of combined treatment with mycophenolate mofetil and corticosteroids in advanced immunoglobulin A nephropathy: Sang Youb Han, Chan-Young Jung, Sang Ho Lee et al.; Kidney Res Clin Pract. 2022;41(4):452-461. Published online May 4, 2022; DOI: https://doi.org/10.23876/j.krcp.21.146; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Serum interferon-γ and urinary monocyte chemoattractant peptide-1 are important factors in the pathogenesis of immunoglobulin A nephropathy: Sang Youb Han, Kyung Hwan Jeong, Chun-Gyoo Ihm, Young Sun Kang, Dae Ryong Cha; Kidney Res Clin Pract. 2021;40(1):69-76. Published online March 12, 2021; DOI: https://doi.org/10.23876/j.krcp.20.157
Cited By 2; Full text PubReader ePub Crossref - TDM PDF Supplementary Material

Physicians’ perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey: Ran-hui Cha, Su Hyun Kim, Eun Hui Bae et al.; Kidney Res Clin Pract. 2019;38(3):373-381. Published online September 30, 2019; DOI: https://doi.org/10.23876/j.krcp.19.007
Cited By 4; Full text PubReader Crossref - TDM PDF Supplementary Material

Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pag: Ran-hui Cha, Shin Wook Kang, Cheol Whee Park et al.; Kidney Res Clin Pract. 2018;37(1):98-99. Published online March 31, 2018; DOI: https://doi.org/10.23876/j.krcp.2018.37.1.98; Full text PubReader Crossref - TDM PDF

Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis: Sollip Kim, Hyun-Jung Kim, Hyeong-Sik Ahn et al.; Kidney Res Clin Pract. 2017;36(3):274-281. Published online September 30, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.3.274
Cited By 29; Full text PubReader Crossref - TDM PDF Supplementary Material

Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea: Ran-hui Cha, Shin Wook Kang, Cheol Whee Park et al.; Kidney Res Clin Pract. 2017;36(1):68-78. Published online March 31, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.1.68
Cited By 25; Full text PubReader Crossref - TDM PDF Supplementary Material

Plasma leptin concentrations are greater in type II diabetic patients and stimulate monocyte chemotactic peptide-1 synthesis via the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway: Jin Joo Cha, Young Youl Hyun, Yi Hwa Jee et al.; Kidney Res Clin Pract. 2012;31(3):177-185. Published online June 26, 2012; DOI: https://doi.org/10.1016/j.krcp.2012.06.004; Full text PubReader Crossref - TDM PDF

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

MOST VIEWED MOST CITED

5,402	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
3,910	Korean Society of Nephrology 2022 Recommendations on controversial issues in diagnosis and management of hyponatremia
3,890	Renal side effects of COVID-19 vaccines in patients with immunoglobulin A nephropathy
8,243	Pediatric acute kidney injury: new advances in the last decade
5,634	Diagnosis of renal transplant rejection: Banff classification and beyond

Cited By 35	Mitochondrial dysfunction in kidney injury, inflammation, and disease: potential therapeutic approaches
Cited By 22	Trends in epidemiologic characteristics of end-stage renal disease from 2019 Korean Renal Data System (KORDS)
Cited By 21	Diagnosis of renal transplant rejection: Banff classification and beyond
Cited By 21	The KNOW-CKD Study: What we have learned about chronic kidney diseases
Cited By 18	Korean clinical practice guidelines for preventing transmission of coronavirus disease 2019 (COVID-19) in hemodialysis facilities

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr